Glycopeptide-functionalized gold nanoparticles for antibody induction against the tumor associated mucin-1 glycoprotein.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2016-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2016.01.044PMID 26853835
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis of tumor-associated MUC1-glycopeptides and their multivalent presentation by functionalized gold colloids.

  2015cited by this paper
• Gold nanoparticle mediated cancer immunotherapy.

  2014cited by this paper
• Gold Nanoparticles Displaying Tumor‐Associated Self‐Antigens as a Potential Vaccine for Cancer Immunotherapy

  2014cited by this paper
• Nanoparticle vaccines.

  2014cited by this paper
• Self-adjuvanting synthetic antitumor vaccines from MUC1 glycopeptides conjugated to T-cell epitopes from tetanus toxoid.

  2013cited by this paper
• Glyconanotechnology.

  2013cited by this paper
• Synthetically defined glycoprotein vaccines: current status and future directions

  2013cited by this paper
• High-density sub-100-nm peptide-gold nanoparticle complexes improve vaccine presentation by dendritic cells in vitro

  2013cited by this paper
• ‘Multicopy Multivalent’ Glycopolymer-Stabilized Gold Nanoparticles as Potential Synthetic Cancer Vaccines

  2013cited by this paper
• Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo.

  2012cited by this paper
• Variation of the glycosylation pattern in MUC1 glycopeptide BSA vaccines and its influence on the immune response.

  2012cited by this paper
• Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.

  2012cited by this paper
• Gold nanoparticles in biomedical applications: recent advances and perspectives.

  2012cited by this paper
• The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.

  2011cited by this paper
• Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

  2011cited by this paper
• Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer.

  2011cited by this paper
• Synthetic antitumor vaccines containing MUC1 glycopeptides with two immunodominant domains-induction of a strong immune response against breast tumor tissues.

  2011cited by this paper
• Conjugation of peptides to the passivation shell of gold nanoparticles for targeting of cell-surface receptors.

  2010cited by this paper
• The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

  2009cited by this paper
• A synthetic vaccine consisting of a tumor-associated sialyl-T(N)-MUC1 tandem-repeat glycopeptide and tetanus toxoid: induction of a strong and highly selective immune response.

  2009cited by this paper
• Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response.

  2008cited by this paper
• Varied presentation of the Thomsen-Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticles.

  2008cited by this paper
• Applications of Nanoparticles in Biology

  2008cited by this paper
• Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines.

  2007cited by this paper
• Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview.

  2005cited by this paper
• O-Linked Glycosylation in the Mammary Gland: Changes that Occur During Malignancy

  2001cited by this paper
• Immunobiology of dendritic cells.

  2000cited by this paper
• Pathways of O-glycan biosynthesis in cancer cells.

  1999cited by this paper
• Comparison of O-Linked Carbohydrate Chains in MUC-1 Mucin from Normal Breast Epithelial Cell Lines and Breast Carcinoma Cell Lines:

  1996cited by this paper
• Interleukin‐12 profoundly up‐regulates the synthesis of antigen‐specific complement‐fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo

  1995cited by this paper
• Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.

  1995cited by this paper
• T antigen, a tumor marker against which breast, lung and pancreas carcinoma patients mount immune responses.

  1983cited by this paper

• Potential of gold nanoparticles conjugated with tumor antigens for cancer immunoprophylaxis

  2025cites this paper
• Balancing Antigen Loading on Gold Nanoparticles: Implications for Future Cancer Vaccine Strategies

  2025cites this paper
• Detection of Tumor-Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes.

  2024cites this paper
• Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer

  2024cites this paper
• Nanomaterials in Cancer Immunotherapy: A Spotlight on Breast Cancer

  2023cites this paper
• Biomaterial-based Platforms for Modulating Immune Components against Cancer and Cancer Stem Cells.

  2023cites this paper
• Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens

  2023cites this paper
• Tertiary lymphoid structure and decreased CD8+ T cell infiltration in minimally invasive adenocarcinoma

  2022influential citation
• Metal-based nano-vaccines for cancer immunotherapy

  2022cites this paper
• Immunization of Mice with Gold Nanoparticles Conjugated to Thermostable Cancer Antigens Prevents the Development of Xenografted Tumors

  2022cites this paper
• The Shape of Nanostructures Encodes Immunomodulation of Carbohydrate Antigen and Vaccine Development.

  2022cites this paper
• Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates

  2022cites this paper
• Harnessing the Immunogenic Potential of Gold Nanoparticle-Based Platforms as a Therapeutic Strategy in Breast Cancer Immunotherapy: A Mini Review

  2022cites this paper
• Recent advances and future perspectives on carbohydrate-based cancer vaccines and therapeutics.

  2022cites this paper
• Glycans as Targets for Drug Delivery in Cancer

  2022cites this paper
• Nanoparticle Shape Governs Immunomodulation of MUC1 Antigen to Develop Anti-cancer Vaccine

  2021cites this paper
• The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines

  2021cites this paper
• Biomedical applications of the peptide decorated gold nanoparticles

  2021cites this paper
• Recent advances on smart glycoconjugate vaccines in infections and cancer

  2021cites this paper
• Structure-based Design of Anti-cancer Vaccines: The Significance of Antigen Presentation to Boost the Immune Response.

  2021cites this paper
• Nanostructured gold in ancient Ayurvedic calcined drug ‘swarnabhasma’

  2021cites this paper
• The Development of Vaccines from Synthetic Tumor‐Associated Mucin Glycopeptides and their Glycosylation‐Dependent Immune Response

  2021cites this paper
• Cell‐Membrane‐Display Nanotechnology

  2020cites this paper
• Recent Advances in Peptide-Based Approaches for Cancer Treatment.

  2020cites this paper
• Gold, Silver, and Palladium Nanoparticles: A Chemical Tool for Biomedical Applications

  2020cites this paper
• Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design.

  2020cites this paper
• Gold nanoparticle-based platforms for vaccine development.

  2020cites this paper
• Tertiary Lymphoid Structure and CD8 T Cell Exclusion in Minimally Invasive Adenocarcinoma

  2020cites this paper
• Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges

  2020cites this paper
• Synthesis and Immunological Evaluation of a Single Molecular Construct MUC1 Vaccine Containing l-Rhamnose Repeating Units

  2020cites this paper
• Structure-Based Design of Potent Tumor-Associated Antigens: Modulation of Peptide Presentation by Single-Atom O/S or O/Se Substitutions at the Glycosidic Linkage.

  2019cites this paper
• Nanoparticles Advancing Cancer Immunotherapy

  2019cites this paper
• Peptide Delivery Systems for Cancer Vaccines

  2018cites this paper
• Peer-reviewed version of the manuscript published in final form at Chemical Society Reviews (2018) Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications

  2018cites this paper
• Design of Gold Nanoparticles in Dendritic Cell‐Based Vaccines

  2018cites this paper
• Exploring gold nanoparticles interaction with mucins: A spectroscopic-based study.

  2018cites this paper
• Targeted cancer therapy through antibody fragments‐decorated nanomedicines

  2017cites this paper
• Microarray Analysis of Antibodies Induced with Synthetic Antitumor Vaccines: Specificity against Diverse Mucin Core Structures.

  2017cites this paper
• Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines

  2017cites this paper
• Cell membrane-derived nanomaterials for biomedical applications.

  2017cites this paper
• Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines †

  2017cites this paper
• Glycoproteins functionalized natural and synthetic polymers for prospective biomedical applications: A review.

  2017cites this paper
• Immunological properties of gold nanoparticles

  2016cites this paper
• Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines

  2016influential citation
• Environmental Research and Public Health New Immunotherapy Strategies in Breast Cancer

  year unknowncites this paper